Global COVID-19 diagnostic testing market to amass USD 44481.8 million in 2020
/
Date01 Jun 2020
Email Print Friendly Share Selbyville, Delaware, June 01, 2020 (GLOBE NEWSWIRE) — With inception in Wuhan in December of 2019, COVID-19 has rapidly spread across... Read More →
Aktia’s acquisition of Alandia's life insurance portfolio completed
/
Date01 Jun 2020
Email Print Friendly Share Aktia Bank PlcPress release1 June 2020 at 9.00 a.m. Aktia’s acquisition of Alandia’s life insurance portfolio completed Aktia Bank Plc and... Read More →
Occidental Announces Dividend
/
Date01 Jun 2020
Email Print Friendly Share HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Occidental Petroleum Corporation (NYSE:OXY) said today that its Board of Directors has declared a... Read More →
AS VALMIERAS STIKLA ŠĶIEDRA neauditēta konsolidēta finanšu informācija par 2020. gada pirmajiem 3 mēnešiem
/
Date01 Jun 2020
Email Print Friendly Share AS VALMIERAS STIKLA ŠĶIEDRA publicē uzņēmuma vadības ziņojumu un neauditēto konsolidēto finanšu informāciju par 2020. gada pirmajiem trīs mēnešiem, ar kuru... Read More →
GROUPE PARTOUCHE BUYS THE CLUB BERRI AND HOLDS A PARISIAN GAMING CLUB
/
Date01 Jun 2020
Email Print Friendly Share Groupe Partouche announces having bought this day, mainly from the company Delahaye & Co1, 95% of the shares of the company... Read More →
REMINDER/Media Advisory: BRP Will Present Its First Quarter FY2021 Results and Hold Its Annual Meeting of Shareholders
/
Date01 Jun 2020
Email Print Friendly Share VALCOURT, Quebec, May 28, 2020 (GLOBE NEWSWIRE) — BRP Inc. (TSX:DOO; NASDAQ:DOOO) will hold its first quarter FY2021 financial results conference... Read More →
Publication of G4S International Finance plc's 2019 Annual Report and Financial Statements
/
Date01 Jun 2020
Email Print Friendly Share 29 May 2020 G4S International Finance plc Publication of Annual Report and Financial Statements for year ended 31 December 2019 G4S... Read More →
Celyad Provides Update on Allogeneic CAR-T Franchise including CYAD-101 and shRNA Platform at the 2020 ASCO Virtual Scientific Program
/
Date01 Jun 2020
Email Print Friendly Share First-in-class TIM-based non-gene edited allogeneic CAR-T candidate, CYAD-101, shows encouraging clinical activity with no evidence of graft-versus-host disease in relapsed/refractory metastatic... Read More →